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Abstract
The availability of material for experimental studies is a key constraint in the
development of full‐scale bioprocesses. This is especially true for the later stages in a
bioprocess sequence such as purification and formulation, where the product is at a
relatively high concentration and traditional scale‐down models can require
significant volumes. Using a combination of critical flow regime analysis, bioprocess
modelling, and experimentation, ultra scale‐down (USD) methods can yield bioprocess
information using only millilitre quantities before embarking on highly demanding
full‐scale studies. In this study the performance of a pilot‐scale tangential flow
filtration (TFF) system based on a membrane flat‐sheet cassette using pumped flow
was predicted by devising an USD device comprising a stirred cell using a rotating
disc. The USD device operates with just 2.1 cm2 of membrane area and, for example,
just 1.7 mL of feed for diafiltration studies. The novel features of the design involve
optimisation of the disc location and the membrane configuration to yield an
approximately uniform shear rate. This is characterised using computational fluid
dynamics for a defined layer above the membrane surface. A pilot‐scale TFF device
operating at ~500‐fold larger feed volume and membrane area was characterised in
terms of the shear rate derived from flow rate‐pressure drop relationships for the
cassette. Good agreement was achieved between the USD and TFF devices for the
flux and resistance values at equivalent average shear rates for a monoclonal
antibody diafiltration stage.
K E YWORD S
CFD, membrane, monoclonal antibody diafiltration, TFF, ultra scale‐down
1 | INTRODUCTION
Membrane‐based operations are ubiquitous in industrial processes
including biomanufacturing. They offer the potential of scalability
and robustness without requiring additional chemicals or harsh
conditions to operate (Cui & Muralidhara, 2010; Lutz, 2015). The use
of membranes in bioprocessing, for example of therapeutic proteins,
includes initial removal of particulates such as cells or cell debris,
impurity clearance using viral and sterile filters, concentration and
diafiltration for feed preparation to chromatography stages or for
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final formulation (Rathore & Shirke, 2011). Membrane structures
may be designed to retain macromolecules, generally termed
ultrafiltration, or to retain particulates, generally termed microfiltra-
tion. Membrane operations may operate in either tangential flow
(cross‐flow) filtration (TFF) mode to reduce fouling of the membrane
surface, or in normal flow (dead‐end) filtration (NFF) mode often for
the removal of trace particulates.
Industrial modules can be operated in different configurations
including batch, fed‐batch, single‐pass, and feed‐and‐bleed/continuous
(Holzer, 2017). Continuous or feed‐and‐bleed operations are common
at large‐scale but for many bioprocessing applications, batch operation
is used with the option of an additional feed for diafiltration stages
(Cheryan, 1998; van Reis & Zydney, 2007). This article will focus on the
use of an ultrafiltration membrane for a diafiltration stage operating in
TFF batch mode. Membrane geometries for TFF include hollow fibre,
spiral wound, and flat‐sheet, the last being the form typically found in
bioprocessing for therapeutics (Lutz, 2015). The flat sheets are
commonly mounted into cassettes, these being compact rectangular
units with smaller footprint consisting of multiple flat sheet membranes
layered with flow channel spacers. These spacers often incorporate
turbulence promoters to help reduce membrane fouling and to increase
the bulk mass transfer at the membrane surface (Shrivastava, Kumar, &
Cussler, 2008). This format allows reduced hold‐up volumes and
improved permeate flux, hence decreasing the exposure of process
material to shear stress during pumping and flow (Lutz, 2015).
Mechanically agitated systems have been devised to increase shear
over the membrane whereas still operating at low flow rates, for
example, using an axial rotating cylinder (Holeschovsky & Cooney,
1991; Ji et al., 2016; Kroner & Nissinen, 1988) or a rotating disc
(Ebrahimi, Schmitz, Kerker, Liebermann, & Czermak, 2013).
Scale down of membrane systems to bench scale poses significant
challenges. It is necessary to maintain flow path length and similar
wall and entrance effects to help mimic hydrodynamic shear
characteristics, while also ensuring the pumping and piping flow
effects remain the same. Rayat, Lye, and Micheletti (2014) used an
equivalent hydraulic length to account for flow disruption effects in a
channel with changes in flow direction to successfully mimic the
pressure drops and shear rates present in full‐scale TFF systems
thereby reducing the membrane area used to 10 cm2. Stirred‐well
systems have been used, where the intention is to maintain a clear
membrane surface, to study environmental effects on protein
processing such as pH and salt concentration using membrane areas
of 0.25 cm2 in multi‐well plates (Kazemi & Latulippe, 2014) or the
effects of membrane pore size and composition on the specific
transmission of proteins using 1.5 cm2 membrane discs (LaRue,
Kazemi, & Latulippe, 2018).
Membrane separation processes are often scaled by maintaining
the same membrane loadings and membrane configurations (i.e., path
length) and varying the number of membrane channels (i.e., the
number of membrane sheets for cassette formats; van Reis et al.,
1997). Scale‐down systems have been developed with capacity ratios
of 1:100 to 1:400 resulting in membrane area requirements of
10–50 cm2 (Brose, Dosmar, Cates, & Hutchison, 1996; Rayat et al.,
2014). These systems, however, still require 100s of millilitres of feed
material. Often they do not directly mimic larger scale operation
because of differences in the pump hydrodynamic environment, the
required number of passes, and the magnitudes of shear rate
(Meireles, Aimar, & Sanchez, 1991).
Ultra scale‐down (USD) technologies use experimentation at the
millilitre scale to help understand the impact of the large-scale
process environment. USD conditions may be defined by combining
critical flow regime analysis and bioprocess modelling of large-scale
systems (Rayat, Chatel, Hoare, & Lye, 2016; Titchener‐Hooker,
Dunnill, & Hoare, 2008). USD techniques often incorporate the
ability to mimic the full‐scale shear environment and flow patterns to
study the impact on the stability of biological materials (Biddlecombe
et al., 2007; Reid et al., 2010).
USD methodologies are able to offer a wider understanding of the
effect of individual parameters by decoupling dependencies, for
example, shear stress in the entry zone of a continuous flow
industrial‐scale centrifuge, sedimentation in the settling zone, and shear
stress during sediment discharge (Boychyn et al., 2001, 2004; Chan
et al., 2006). The use of USD techniques has been described for
chromatography (Wenger, Dephillips, Price, & Bracewell, 2007;
Willoughby, Martin, & Titchener‐Hooker, 2004), NFF (Lau et al., 2013;
Reynolds et al., 2003), for membrane separations in normal‐flow mode
(Jackson, Liddell, & Lye, 2006; Rayat, Micheletti, & Lye, 2010), in cross‐
flow mode using pumped flow (Rayat et al., 2014), and in mechanically‐
agitated mode using a rotating disc (Ma et al., 2009). This latter form of
the USD device allows the flow over the membrane to be varied
independently of the transmembrane flux or pressure. It has been used
to study microfiltration for antibody fragment recovery from clarified
Escherichia coli lysates (Ma et al., 2009) and human cell recovery (Masri,
Lawrence, Wall, & Hoare, 2017). This article addresses the challenge of
characterizing the shear rate over the membrane in such a way that it
can be related to shear rate in full‐scale operations. An important
precursor is the need to redesign the USD device so that all the
membrane may be considered to be exposed to the same shear rate.
The objective of this study was to characterise the redesigned USD
device and the relationship to the performance of a flat‐sheet
membrane cassette in a pilot‐scale TFF system. The membrane
performance, using flux as a comparative measure, was studied for a
diafiltration operation of a monoclonal antibody (mAb) solution. This
type of operation was selected to solely focus on the membrane
performance over time, i.e., while the protein concentration remains
unchanged. Ultra scale‐down studies of membrane performance were
carried out over a range of shear rates encompassing those which are
observed at full scale. A characteristic average shear rate was the
scaling parameter used to compare performance at the two scales.
2 | MATERIALS AND METHODS
2.1 | Materials
A humanized monoclonal antibody (IgG), referred to as mAb‐1
(~150 kDa, pI 9.0) was provided by Merck & Co., Inc (Kenilworth, NJ).
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It was supplied as two frozen (− 80°C) samples (2 L aliquot at 12 g/L)
stored in 10mM Sodium Acetate buffer pH 5.5. The frozen samples
were thawed overnight before preparation through diafiltration into
10mM Tris Acetate buffer pH 5.4. The resulting solution at 12 g/L was
used for pilot‐scale TFF and USD studies within 24 hr of thawing. This
concentration was representative of a feed for final membrane
bioprocessing stages.
Pilot‐scale data was obtained using a 0.11m2 membrane cassette
(C‐screen Pellicon 3, Ultracel PLCTM, composite regenerated cellu-
lose, molecular weight cut‐off (MWCO) = 30 kDa, EMD Millipore,
Bedford, MA). USD data was obtained using membrane filter discs
(Ø = 25mm, Ultracel PLCTM, composite regenerated cellulose,
MWCO= 30 kDa, EMD Millipore). All chemicals used for buffer
preparation were from Sigma‐Aldrich (St. Louis, MO) unless other-
wise stated. Buffers were vacuum filtered before use (SteritopTM
vacuum bottle‐top filters, 0.22 µm pore size, EMD Millipore).
2.2 | Equipment
The rheology of the feed and diafiltration buffer (10mM Tris Acetate
pH 5.4) was determined using a capillary viscometer (m‐VROC,
RheoSense©, San Ramon, CA) as a function of time, shear rate and
temperature.
A purpose‐designed TFF unit was used for pilot‐scale studies
(PendoTECH TFF Process Control SystemTM, PendoTECH, Princeton,
NJ) fitted with a membrane cassette and operated using a quaternary
diaphragm pump (QuattroFlowTM 150 S, Triangle Process Equipment,
Wilson, NC). Pressure was measured by sensors (PREPS‐N‐025,
PendoTECH) located in the feed and retentate lines. The permeate
line was left open to atmosphere. The diafiltration tank (10 L) and the
feed tank (1 L) were linked via a peristaltic pump (Masterflex® L/STM,
Cole‐Parmer Instrument Company, Vernon Hills, IL). The required
mean transmembrane pressure drop, ΔP̅TMP, was achieved through
automatic adjustment of a pinch‐valve on the retentate line. All pilot‐
scale TFF trials were performed at 20.5 ± 0.5°C (room temperature).
The USD device was designed and fabricated in house (Rapid Design
and Fabrication Facility, Department of Biochemical Engineering, UCL,
UK) and is detailed in Figure 1. The device comprises a perspex chamber
(h =56mm, Ø =21mm, 1.7mL capacity) with a stainless steel base that
includes a support frit to accommodate the membrane disc, a permeate
outlet port, and a jacketed‐housing to provide a controlled temperature
environment within the chamber by using a recirculating water bath
(211‐131‐100, Fisher Scientific™, Loughborough, UK).
Stainless steel rotating discs of various designs (Ø = 15mm) could
be mounted at a specified distance (from 0.8 to 2.0 mm) above the
membrane surface and driven at a specified speed up to 5,000 rpm
using a top‐mounted stepper motor (D8‐MD81‐011, M‐1713‐1.5 S
Schneider Electric Motion, Marlborough, MA). Selected areas of the
membrane filter were blanked, reducing effective membrane area
from 3.46 to 2.1 cm2, by placing 0.1 mm‐thick stainless steel inserts
(Advanced Chemical Etching Ltd, Shropshire, UK) in specified
locations on the membrane. These were placed using a custom‐built
mould (Rapid Design & Fabrication Facility, UCL) with a vacuum pick‐
up tool (624–9829, RS Components, Northants, UK) and held in place
to fix location using a medical grade glue (Loctite 4011, Henkel AG &
Co, KGaA, Berkeley, CA). The perspex chamber is equipped with
three ports, one for the feed from a syringe pump (Harvard PHD
Ultra Syringe pump 4400, Harvard Apparatus Ltd, Edenbridge, UK), a
second for a pressure sensor (40PC100G2A, Honeywell Sensors and
Control, Golden Valley, MN), which is connected to a multifunction
data acquisition device (National Instruments Corporation Ltd,
Berkshire, UK), and a third for a thermocouple data logger (EL‐
GFX‐TC, Lascar Electronics Ltd, Wiltshire, UK).
Constant pressure operation was enabled using the pressure
sensor to determine the syringe pump setting (LabVIEW 2015,
National Instruments Corporation Ltd). All experiments were carried
out at constant transmembrane pressure of 1.0 bar and at a
controlled temperature of 20.0 ± 0.3°C by circulating cooling water
(10°C) through the jacketed‐base of the USD device.
2.3 | Experimental methods
For the pilot‐scale TFF experiments, 0.1M NaOH was first drained from
the system and the inline cassette was replaced by a new one. Two
washing stages (initially full recirculation and then open permeate line)
were performed using ~1.0 L of ultra‐pure water (0.22 µm filtered from a
MilliQ station) to flush the cassette storage solution at a cross flow rate
F IGURE 1 Simplified schematic representation of each individual
component of the USD membrane system. There are ten main
components: (a) motor; (b) perspex chamber with three ports;
(c) pressure sensor; (d) feed syringe pump connector; (e)
thermocouple; (f) rotating disc; (g) membrane; (h) seal; (i) filtration
base to accommodate the membrane disc; (j) support frit providing a
jacketed‐housing for cooling system; (k) permeate outlet port. Note
that the drawing is not drawn to scale
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(QF) of 0.4 L/min. The membrane resistance (RM) was determined from
the flux rate (QD) of ultra‐pure water required to reach ΔPTMP of 1.0 bar
(In all cases steady‐state conditions were achieved within 15min and the
use of the membranes was continued). The system was flushed with
~1.0 L of diafiltration buffer, 10mM Tris Acetate (pH 5.4) at a cross QF of
0.4 L/min and then manually filled, avoiding foam formation, with a feed
volume of 0.89 L of the antibody solution. Diafiltration operation was
performed at a ΔPTMP of 1.0 bar. The diafiltration buffer was fed to
maintain feed volume constant for a total of seven diafiltration volumes
(DV). Permeate flux (J) was determined by the measurement of the
permeate fraction weights every 0.1min for theQF tested. On completion
the protein concentration in the retentate was recorded. Cleaning was
performed by flushing 0.1M NaOH for 30min at QF=0.4 L/min. The
system was primed and stored at room temperature in 0.1M NaOH.
For each USD run, a new filter disc was placed during the set‐up of
the USD system. A wash stage was performed using 9mL of ultra‐pure
F IGURE 2 Effect of USD device design on shear rate profiles using CFD simulations. Different disc designs (angle ϴ) and heights above the
membrane at the disc centre (D1) and edge (D2) are studied: (a) D1 = 0.6 mm, D2 = 1.1 mm and ϴ = 3.4°; (b) D1 = 1.6, D2 = 2.0mm and ϴ = 3.4°; (c)
D1 =D2 = 2.0 mm and ϴ = 0°; (d) D1 =D2 = 2.0 mm and ϴ = 0° with blanking of inner and outer sections of the membrane. Shear rate flow vectors
are shown to be 0.1 mm above the membrane surface in two different planes: (i) cross‐sectional, (ii) longitudinal, and (iii) as the profile of mean
shear rates of fluid elements for a disc speed of 2,500 rpm and viscosity of 0.0013 Pa s. A characteristic overall average shear rate (yāv) over the
membrane is given for each design [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 3 Effect of disc speed and viscosity on shear rate profiles for USD configuration shown in Figure 2d. The combination of disc
speeds and viscosities studied are as follows: (a) 1,300 rpm and 0.0013 Pa s; (b) 5,000 rpm and 0.0013 Pa s; (c) 2,500 rpm and 0.0016 Pa s;
and (d) 2,500 rpm and 0.0020 Pa s. Figure 2d shows profiles obtained at 2,500 rpm and 0.0013 Pa s. See Figure 2 legend for further
description [Color figure can be viewed at wileyonlinelibrary.com]
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water for 30min. The RM was determined from the QD of ultra‐pure
water required to reachΔPTMP of 1.0 bar. Where steady‐state conditions
were not achieved within 15min, the filter disc was discarded. The USD
system was flushed with 9mL of diafiltration buffer at a QD of 86 LMH
(0.3mL/min) before manually filling the stirred cell chamber with a feed
volume of 1.7mL of the antibody solution, i.e., its maximum capacity.
This prevented the formation of air‐liquid interfaces and consequently
the development of a vortex even at high disc speeds.
The QF of the diafiltration buffer was adjusted to result in a
ΔPTMP of 1.0 bar until completion of seven DV. Permeate flux (J)
was determined from the diafiltration pump flow rate and
recorded every 0.02 min for each disc speed tested. Upon
completion of the USD test, the concentration of the antibody
solution in the chamber was recorded and a visual inspection made
for any significant protein deposits remaining. Cleaning
was performed by flowing 0.1 M NaOH at a QD of 86 LMH
(0.3 mL/min) at N = 3,000 rpm. The system was then drained and
rinsed with water and the membrane was discarded.
2.4 | Computational methods
Shear rate analysis for flow in the USD‐stirred cell was performed
using computational fluid dynamics simulations (Ansys, Inc., CFX
version 17.0, Canonsburg, PA, run on an Intel® Xeon® CPU
E5–2687W with two processors of 3.4 GHz with 256 Gb RAM
memory). Because of rotational symmetry, only a quarter of the disc
was modelled as a 3D cross section. The rotating disc was set as an
individual wall boundary with no slip. The model selected was shear
stress transport, i.e., a combination of k‐ε, which provides an initial
overview of the flow conditions and k‐ω, which improves accuracy of
the results by solving the basic momentum transport equations in
radial, axial, and azimuthal components, particularly near the
chamber wall and the boundaries.
All simulations were meshed with 11million elements and
iterated until reaching the defined number of iterations of 200 and
converging within a root mean square (RMS) of 1e−4 s−1 for the shear
rate values. Each simulation required ~9 hr process time to complete.
The chosen mesh element size and convergence conditions gave
reasonably accurate results at an acceptable process time for each
simulation.
A characteristic average shear rate was the chosen basis for scale
translation between the USD and the pilot‐scale TFF systems. In the
USD system this was defined as the average shear rate in a 0.1 mm
height of fluid above the active area of the membrane surface. This
height is similar in magnitude to an effective individual channel
height in flat‐sheet cassettes (Rayat et al., 2014).
For the pilot‐scale TFF system, the shear rate was estimated
using Equation (1), where the axial pressure drop, ΔP̅axial, was
measured experimentally with ultra‐pure water and the cassette
hold‐up volume (V) was obtained from the manufacturer (EMD
Millipore) (Binabaji, Ma, Rao, & Zydney, 2015).
̅ μ=
Δ

y
Q P
V
av
F axial
F
(1)
3 | RESULTS AND DISCUSSION
3.1 | Computational fluid dynamics
The flow conditions were characterized for a range of disc designs
and placements. These were varied with a view to achieving an
approximately uniform shear rate across the membrane surface as is
likely to be present during fluid flow in the pilot‐scale TFF membrane
cassette. Some examples studied for the USD device operating in the
mid‐speed range available are given in Figure 2. The initial USD
design (Figure 2a) was as studied previously (Ma et al., 2009) with a
conical disc close to the membrane surface with the assumption that
a narrowing gap might partially offset the decreasing angular velocity
to give a more uniform shear rate. However, the majority of radial
flow is predicted to occur above the disc with just one flow vortex
beneath the edge of the disc and the chamber wall (Figure 2a [i] and
[ii]). A sharp shear rate profile results with ymin = 300 and ymax =
7,600 s−1 (Figure 2a [iii]).
Raising the disc (Figure 2b) allowed the flow vortex to cover
greater portions of the membrane, i.e., rather than have the majority
of radial flow above the disc (Figure 2b [i]). A critical minimum
distance (D2) of at least 1.35mm between membrane surface and
disc edge was found for a range of disc angles to be necessary to
allow radial flow over the membrane surface and improve the
uniformity of shear rate albeit still with a sharp profile (ymin = 200
and ymax = 3,000 s
−1, Figure 2b [iii]). Further simulations, for example,
Figure 2c showed that the disc angle did not impact flow over the
membrane provided the critical distance (D2) between the disc and
membrane was maintained.
For the design shown in Figure 2c, the regions were identified where
the shear rate over the membrane was predicted to be less than 0.8 yav,
i.e., a central region and an outer annulus. These regions were blanked
TABLE 1 Comparison of the USD and the pilot‐scale TFF systems
and their operation
Ultra scale‐down
(USD) system
Pilot‐scale TFF
system
Effective membrane
area, m2
0.00021a 0.11b
Feed volume of
material required per
experiment, L
0.0017 0.89
Pressure drop
characterisation
Δ = −P P PTMP R P Δ ¯ = −( + )P PP PTMP
2
P
F R
Operation Constant ΔPTMP
c Constant ΔP̅TMP
d
Shear rate
characterisation
f (N) using CFD f (QF, ΔPaxial)
aSee Section 2 for further details.
bManufacturer’s definition.
cAchieved using feedback loop control to adjust syringe pump flux rate.
dAchieved using adjustable pinch‐valve on retentate outlet stream.
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(Figure 2d) resulting in an acceptably uniform shear rate over the
remaining exposed membrane surface with yāv of 2,800 s
−1 (ymin=2,300
and ymax=3,000 s
−1, Figure 2 d [iii]). The use of 0.1mm-thick blanking
pieces led to little change in the flow patterns in the USD chamber and no
significant regions of low shear adjacent to the membrane and at the
stepped edge of the blanking pieces (Figure 2d [i]). The final design is
shown in Figure 2d was studied for other disc speeds and viscosities with
examples shown in Figure 3. Similarly uniform shear profiles over the
membrane are observed in all cases.
3.2 | Design of scale‐down TFF experiments
Comparison of USD and pilot‐scale TFF systems was performed at a
constant volumetric membrane loading; 8.1 L of feed/m2. Table 1 further
describes the properties of the two systems and these are represented
schematically in Figure 4 for the resultant USD membrane area as
defined in Figure 2d.
Figure 5a summarises the predicted average shear rate versus disc
speed for the USD device design chosen for further study (Figure 2d) for
F IGURE 4 Schematic representation
of (a) ultra scale‐down (USD) and
(b) pilot‐scale TFF membrane systems
(drawings are not to scale). In this study,
the volume required for the USD system is
approximately 520‐fold smaller than for
the pilot‐scale setup. A comparison
between these systems is given in Table 1
F IGURE 5 Comparison of shear rate (yāv) relationships for (a) USD as a function of disc speed using CFD analysis and (b) pilot‐scale
TFF using measured ∆Paxial for set QF values. In (a), yāv is predicted using CFD for the mAb solution to be studied (µ = 0.0013 Pa s). In (b),
calculated y ̄av for water (○) is obtained from the measured ∆Paxial of water and µ ( = 0.0010 Pa s). The predicted y ̄av for the protein
solution (■), is obtained from the measured ∆Paxial of water, assuming ∆Paxial ≠ f(µ) for transitional and turbulent flow
(1,400 < Re < 7,000), and µ = 0.0013 Pa s, using Equation (1). The calculated yāv for the protein solution (□) is determined from the
measured ∆Paxial of protein and µ = 0.0013 Pa s
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the process stream studied here (µ=0.0013Pa s). The full CFD results
may be correlated to give ȳav∝N
1.37 µ−0.46 (for 1,300<N<5,000 rpm,
0.0013< µ<0.0020Pa s) similar to a relationship which may be expected
for turbulent flow (e.g., mean velocity gradient∝ (ε/µ)0.5∝ N1.5 µ−0.5,
where ε is power dissipated per unit volume and power dissipated∝ N3
for stirred vessels). A previous study by Ma et al. (2009) similarly
correlated yāv∝ N
1.5 for a USD device with design as shown in Figure 2a.
The strategy for the shear rate characterisation in the pilot scale TFF
F IGURE 6 Flux versus diafiltration volume profiles for (a) USD device operating at different disc speeds (see inset) and (b) pilot‐scale
TFF at different cross flow rates (see inset). Both systems operated at the same ΔPTMP of 1.0 bar. Fresh membranes are used for
each run. Data for single runs are reported here obtained from a moving average of raw data (m = 100), where SD is ~1%. The
protein solution used is a 12 g/L mAb‐1 solution prepared in 10 mM Tris Acetate pH 5.4. The diafiltration buffer was 10 mM Tris
Acetate pH 5.4
F IGURE 7 Effect of (i) membrane
resistance (RM); (ii) steady‐state total
resistance (RT) derived from Figure 6 using
Equation (2); and (iii) steady‐state gel
resistance (RGel) using Equation (3) as a
function of flow conditions represented by
average shear rate, ȳav, related to USD disc
speed (Figure 5a), to pilot‐scale TFF cross
flow rate (see Figure 5b). See Figure 6
legend for the protein solution and buffers
used. The viscosity of permeate (µP) in
Equation (2) was assumed to be the same
as for the diafiltration buffer. Resistance
values are for USD (n = 1) and pilot‐scale
TFF experiments (n = 1). The range bars are
for the s.d. values of the resistance
measurements in the stable region
(3.5 < DV < 7.0). (i) gives mean (_ _ _) ± 1 SD
(‐ ‐) for all membranes used. Note vertical y
axes runs to − 0.6 × 1012m−1 to aid
visualization
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system is based on pressure drop versus flow rate characteristics using
water. This relationship is used with the mAb solution viscosity to predict
the shear rates for the mAb solution (Equation (1) and Figure 5 legend).
These agree with the calculated shear rates using the mAb solution in the
pilot‐scale TFF system. Different strategies will be needed when dealing
with more viscous protein solutions where the flow will be in the laminar
region unlike for these studies (Binabaji, Ma, Rao, & Zydney, 2016). The
predicted shear rates for the mAb solution in the pilot-scale TFF system
(Figure 5b) are within the range of those predicted for the USD device
(Figure 5a).
A diafiltration operation was used to compare the flux
performance of both the USD and pilot‐scale TFF systems for
varying disc speeds or cross flow rates, respectively (Figure 6).
Similar profiles were achieved with higher steady state flux being
achieved for increased flow conditions as expected. In both cases
the membranes behaved similarly with comparable flux profiles
as a function of increasing diafiltration volumes. For both TFF and
USD a decline in protein concentration in solution was observed
on completion of diafiltration, this varied from 10% to 33% for
USD and 6% to 19% for TFF. No visible loss protein deposits were
observable in the USD device and little additional protein was
recovered by water flushing.
3.3 | Using gel resistance as a comparative
measure
Experiments on both scales were compared using gel resistance,
an engineering parameter which, after adjusting for membrane
variability, is based on transmembrane pressure, flux and
material viscosity measurements. The rheology of the mAb‐1
solutions tested showed Newtonian behaviour across the studied
range of viscometer shear rates between 1,000 and 7,000 s−1
(data not shown here). Both clean membrane resistance (RM) and
total resistance (RT) were calculated from steady‐state flux
measurements (Equation (2)). The greater range of the USD disc
membranes can be seen in Figure 7i (i.e., ±1.0 × 1012m−1
compared with ±0.3 × 1012m−1).
⋅ μ=
Δ ¯
R
P
J
x
TMP
SS P
(2)
= − −R R R RGel T M F (3)
F IGURE 8 Comparison of USD and pilot‐scale TFF performance
using CFD predicted yāv for USD to match with experimental yāv for
pilot‐scale TFF: (a) normalised steady‐state flux rates, Ĵ and (b) gel
resistance, RGel. Normalised steady‐state flux (Ĵ ) is given by Equation
(5) using steady‐state flux (JSS) in the stable region (3.5 < DV < 7.0)
from Figure 6 (factor − δ1 varies for USD from 0.8 to 1.3 and for TFF
from 0.9 to 1.1). Gel resistance (RGel) is obtained from Figure 7iii.
Correlations obtained are: (a) Ĵ ∝ yāv0.36, R2 =0.89; and (b) RGel∝ ȳav0.63,
R2 =0.81. Range bars are obtained from s.d. of values in the stable
region (3.5 < DV < 7.0). Note vertical y axis in (b) runs to
− 0.6 × 1012m−1 to aid visualization. See Figure 6 legend for details of
the protein solution and buffers used
F IGURE 9 Suggested use of the USD system to gain early insight into processing of a new candidate and to help determine the design of a
full‐scale TFF system. Step 2 may include a study to establish a design space, for example, N (800–5000 rpm) and ∆PTMP.USD (0.4–1.6 bar) and
also to give an indication of impact on product quality (to be reported in future paper). Step 3 for USD yāv.USD = f (N
1.37µF
−0.46). In Step 4 the
predicted impact of ∆P̅TMP.TFF and QF on the performance may also determine their relevance as critical process parameters
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The resultant gel resistance (RGel) is given by Equation (3)
assuming RF = 0. The values of RM, RT and RGel for various shear
rates are shown in Figure 7. Similar effects were observed of
change in shear rate on gel resistance in the USD and the pilot‐
scale TFF systems (Figure 7iii). At lower shear rates, protein
molecules flow towards the membrane surface and are less
effectively swept away due to weaker cleaning action contributing
to the formation of the gel layer. Gel resistance dominates the
total resistance distribution at low shear rates (<2000 s−1). At
higher shear rates, membrane resistance dominates.
δ = ¯ −R R
R
M M
T
(4)
ˆ = ( − δ)J J 1SS (5)
An adjustment factor, δ (Equation (4)) was determined for each
experiment to account for membrane variability. Normalised
steady‐state flux rates (Ĵ ) Equation (5) and the gel resistance
(RGel) were used to compare experimental runs of both systems at
equivalent characteristic average shear rates, yāv. There is good
agreement in Ĵ and RGel data as shown in Figure 8a,b between USD
and pilot‐scale TFF experimental runs. The coefficient of
0.36 ± 0.04 relating flux and shear rate (Figure 8a) is within the
published range of 0.33–1.33 for different protein ultrafiltration
applications (Cheryan, 1998).
4 | CONCLUSION
The limited availability of material for process development studies,
particularly with high concentration antibody solutions, poses a challenge
to identify optimum operating conditions for a successful scale‐up. A
novel scale‐down approach has been presented in this study to predict
diafiltration performance of a typical pilot‐scale TFF system using flat‐
sheet membrane cassettes by implementing USD technologies. CFD
simulations have been used to characterize flow patterns of the chamber
in the USD system in terms of average shear rate. The match between
the USD and the pilot‐scale TFF system was done using a characteristic
average shear rate as the basis for scale translation. Good agreement of
data was observed when comparing gel resistance and flux of equivalent
experimental runs between scales. This article describes a proof‐of‐
concept study of how USD may be used to determine the effect of
operating variables on membrane performance and hence enhance the
effectiveness of subsequent pilot‐scale experimentation. However the
lack of comparability of protein loss between the USD and TFF devices is
possibly due to the increased surface area to volume in the USD device. If
the USD device is also to be used in preparative mode, there is a need for
redesign to give equivalence to the TFF system.
Figure 9 summarises how the USD system may be used to help
contribute to the design of full‐scale TFF operations. USD experiments
may be conducted to determine membrane performance using flux rate
even when limited amounts of process material are available. The
resultant engineering correlations may be used to predict full‐scale TFF
operation for that process material provided design features of the full‐
scale system are known, for example, operating characteristics with
water. Membrane performance other than flux rate might include the
transmission of contaminants determining the extent of diafiltration
needed. To date the only measure used to validate the shear rate
estimations has been the flux rate and the gel resistance. Other criteria
may be: product recovery, product quality attributes affected by shear
stress, and concentration operations using higher concentrations, which
will be the subject of a future study.
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NOMENCLATURE
D1 distance between the centre of the disc and the membrane
surface
D2 distance between the edge of the disc and the membrane
surface
J permeate flux rate
N disc speed
P fluid pressure
ΔP pressure differential across membrane
Q flow rate
R resistance
V cassette hold‐up volume
Ø diameter
ϴ disc angle
δ adjustment factor
µ viscosity
y ̄ characteristic shear rate
SUBSCRIPTS
av average
D diafiltration buffer
F feed
Gel gel
M membrane
P permeate
R retentate
SS steady‐state
T total
TMP transmembrane pressure
W water
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